Displaying 21 to 35 of 35 investments
| Company | Country | Notes | ||
|---|---|---|---|---|
|
Noxxon Pharma AG Mirror image oligonucleotide drugs. |
Germany | N/A |
|
|
|
Onyvax Ltd Whole-cell allogenic vaccines for cancer. Acquired by VaxOnco Inc. |
United Kingdom | N/A |
|
|
|
PanTherix Ltd A start-up biotech specializing in antibiotic target validation and drug discovery. |
United Kingdom | N/A |
|
|
|
Paradigm Therapeutics Ltd Drug discovery platform company Acquired by Takeda Pharmaceutical Company Ltd in December 2004. |
United Kingdom | N/A |
|
|
|
PIramed Pharma Ltd Oncology Therapeutics. Acquired by Roche in April 2008. |
United Kingdom | N/A |
|
|
|
Plethora Solutions Holdings PLC Discovering and developing urological products. IPO in March 2005. |
United Kingdom | N/A |
|
|
|
ReNeuron Group PLC Treatments for neurological disorders. IPO in August 2005 |
United Kingdom | N/A |
|
|
|
Santhera Pharmaceuticals AG Small molecule therapeutics for neuromuscular and metabolic diseases. IPO in November 2006. |
Switzerland | N/A |
|
|
|
Sosei Co Ltd Identifying new uses for established drugs. Arakis merged with Sosei Co in August 2005. |
Japan | N/A |
|
|
|
Vectura Group PLC Drug formulations and devices for respiratory diseases. IPO in July 2004. |
United Kingdom | N/A |
|
|
|
Virgin Health Bank Ltd Cord blood banking. |
United Kingdom | N/A |
|
|
|
VivoMedica PLC Advancing medical devices from prototype to market. Reversal in to AIM listed company in July 2005. |
United Kingdom | N/A |
|
|
|
Wilex AG Antibody and small molecule cancer therapies. IPO in November 2006 |
Germany | N/A |
|
|
|
XTL Biopharmaceuticals PLC Monoclonal antibody and small molecule therapeutics for Hepatitis. IPO in September 2000. Fully disposed. |
United Kingdom | N/A |
|
|
|
York Pharma PLC Acquisition, development and commercialisation of prescription dermatological products. |
United Kingdom | N/A |